KKR buys into Indian pharma company JB Chemicals, deal could reach $500m
Global private equity giant KKR has agreed to buy a 54% stake in Indian pharmaceutical business JB Chemicals, in a deal which could ultimately see it commit $500m to the company.
Recent Comments